Cover image of the article: Bleeding Episodes Among Patients with Congenital Fibrinogen Disorders, a Study On 12 New Iranian Patients

Image Credit:J Cell Mol Anesth

Bleeding Episodes Among Patients with Congenital Fibrinogen Disorders, a Study On 12 New Iranian Patients

Authors

Majid Naderi1,*, Parvin Rahamani2, Shaban AlizadehShaban Alizadeh ORCID3, Hengam Razavi2, Akbar Dorgalaleh4
1Genetic Researcher Center in Non-Communicable Disease, Zahedan University of Medical sciences, Zahedan, Iran
2Department of Hematology and Blood Transfusion, School of Allied Medical Sciences,Tehran University of Medical Sciences, Tehran, Iran
3Associate Professor ILHA board member Tehran University of Medical Sciences, Tehran, Iran
4Department of Hematology, Allied Medical School, Iran University of Medical Sciences, Tehran, Iran
*Corresponding Author: Genetic Researcher Center in Non-Communicable Disease, Zahedan University of Medical sciences, Zahedan, Iran Email: majid.naderi@gmail.com

Journal of Cellular & Molecular Anesthesia:Vol. 3, issue 1; e150274
Published online:Jan 31, 2018
Article type:Original Articles
How to Cite:Naderi M, Rahamani P, Alizadeh S, Razavi H, Dorgalaleh A. Bleeding Episodes Among Patients with Congenital Fibrinogen Disorders, a Study On 12 New Iranian Patients. J Cell Mol Anesth. 2018;3(1):e150274. doi: https://doi.org/10.22037/jcma.v3i1.19754

Abstract

Background: Congenital fibrinogen disorders (CFDs) comprise about 10% of rare bleeding disorders (RBDs). CFDs are divided into two groups of quantitative (afibrinogenemia and hypofibrinogenemia) with autosomal recessive inheritance pattern, and qualitative (dysfibrinogenemia, hypodysfibrogenemia) disorders, mainly with autosomal dominant inheritance pattern. Sistan and Baluchestan Province in Iran, with its high rate of consanguineous marriages, has a high incidence of RBDs including CFD. In the current study, we report clinical manifestations of patients with CFDs.Methods: Twelve new Iranian patients from Sistan and Baluchestan Province with different types of CFDs were selected for this study. Diagnosis of CFDs was based on clinical features and familial history followed by laboratory assessment by routine and specific coagulation tests including prothrombin time (PT) and activated partial time tests (APTT), as well as FI activity assay by Clauss method.Results: Out of 12 patients, 3(25%) had afibrinogenemia, 7(58.3%) had hypofibrinogenemia while 2(16/7%) were suspected of having dysfibrinogenemia. Although umbilical cord bleeding (UCB) 9(75%) was the most common clinical presentation among the study population, this feature was not observed among patients with dysfibrinogenemia. Hematoma (100%) was the most common presentation of patients with dysfibrinogenemia.? Conclusion: Results of this study revealed that some clinical presentations are the diagnostic features of CFDs and can be used for precise and in-time diagnosis CFDs in conjunction with family history and laboratory findings.Keywords: Fibrinogen Deficiency; Congenital Afibrinogenemia; Blood Coagulation Disorder; Afibrinogenemia

Highlights

References

  • 1.
    References are in the PDF file of the article.

Copyright

© 2018, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

24
Mar
2020
Prevalence of Rare and Common Bleeding Disorders in Kurdistan Province of Iran

Prevalence of Rare and Common Bleeding Disorders in Kurdistan Province of Iran

Akbar Dorgalaleh,
Jamal Rashid Panah,
Bijan Varmaghani,
Peyman Beigi,
Abbas Ahmadi

Dorgalaleh A, Rashid Panah J, Varmaghani B, Beigi P, Ahmadi A. Prevalence of Rare and Common Bleeding Disorders in Kurdistan Province of Iran. J Cell Mol Anesth. 2019;4(4):e149593. doi: https://doi.org/10.22037/jcma.v4i4.29074

7
Aug
2017
Burden of Congenital Factor XIII Deficiency in Iran

Burden of Congenital Factor XIII Deficiency in Iran

Akbar Dorgalaleh

Dorgalaleh A. Burden of Congenital Factor XIII Deficiency in Iran. J Cell Mol Anesth. 2017;2(3):e149544. doi: https://doi.org/10.22037/jcma.v2i3.16263

22
Sep
2020
The Founder Effect? -FXIII Deficiency in Southeast Iran: A Molecular Study Report

The Founder Effect? -FXIII Deficiency in Southeast Iran: A Molecular Study Report

Hojat Shahraki,
Akbar Dorgalaleh,
Majid Fathi,
Shadi Tabibian,
Shahram Teimourian,
Hasan Mollanoori
,et al.

Shahraki H, Dorgalaleh A, Fathi M, Tabibian S, Teimourian S, et al. The Founder Effect? -FXIII Deficiency in Southeast Iran: A Molecular Study Report. J Cell Mol Anesth. 2020;5(4):e149647. doi: https://doi.org/10.22037/jcma.v5i4.31852

14
Jan
2021
Complete Genotype and Clinical Phenotype of Hemophilia B:  A Study on Iranian Patients

Complete Genotype and Clinical Phenotype of Hemophilia B: A Study on Iranian Patients

marzieh shakouri,
Maryam Sadat Hosseini,
Akbar Dorgalaleh,
Minoo Shahidi,
Farhad Zaker

shakouri M, Hosseini MS, Dorgalaleh A, Shahidi M, Zaker F. Complete Genotype and Clinical Phenotype of Hemophilia B: A Study on Iranian Patients. J Cell Mol Anesth. 2021;6(1):e150285. doi: https://doi.org/10.22037/jcma.v6i1.33722

26
Aug
2016
c.559 T>C as The Most Common Mutation of Factor XIII Deficiency in Iranian Patients is not Restricted to Southeast Iran

c.559 T>C as The Most Common Mutation of Factor XIII Deficiency in Iranian Patients is not Restricted to Southeast Iran

Akbar Dorgalaleh,
Shadi Tabibian,
Bijan Varmaghani,
GholamHossein Tamadon,
Hasan Boustani,
Parvin Rahamani
,et al.

Dorgalaleh A, Tabibian S, Varmaghani B, Tamadon G, Boustani H, et al. c.559 T>C as The Most Common Mutation of Factor XIII Deficiency in Iranian Patients is not Restricted to Southeast Iran. J Cell Mol Anesth. 2016;1(4):e149521. doi: https://doi.org/10.22037/jcma.v1i4.13508

More by these authors

Majid NaderiPubMedScholar
Parvin RahamaniPubMedScholar
Shaban AlizadehPubMedScholar
Hengam RazaviPubMedScholar
Akbar DorgalalehPubMedScholar
Share
Cited by
Metrics